Search

everythinglearnresearchcommunity

for

Search:↓

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Testosterone increases certain proteins in the uterus, reducing fluid volume.

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

Sunscreens with higher SPF and UVA filters offer the best protection against skin aging from UVA rays.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

FUE with topical CBD effectively treats stable vitiligo.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

SIRT1-modified stem cells can help treat peritoneal fibrosis by blocking a harmful pathway.

UVA exposure worsens hair loss by activating a specific cell pathway.

Abatacept may help some people with alopecia areata regrow hair.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

Integrative hair therapy improved hair loss and regrowth.

Vogt-Koyanagi syndrome often leads to partial or complete blindness and responds poorly to treatment.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Targeting Vδ1+T-cells may help treat alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.